One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papershttps://doi.org/10.1182/blood.v126.23.680.680
Copy DOI Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 47 |
Affiliation: Amgen (Germany), Amgen (United States), Amgen (United Kingdom), Hochschule Hannover, Hannover Medical School, University Hospital Schleswig-Holstein, University Hospital Regensburg, Goethe University Frankfurt, CHU Dinant Godinne UCL Namur, University of Würzburg, University of Tübingen, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, University of Verona, University Hospital WürzburgLong-Term Outcomes after Blinatumomab Treatment: Follow-up of a Phase 2 Study in Patients (Pts) with Minimal Residual Disease (MRD) Positive B-Cell Precursor Acute Lymphoblastic Leukemia (ALL)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
